Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolemia Panel
Raúl D. SantosLipid Clinic Heart Institute (InCor), University of São Paulo Medical School Hospital, and Preventive Medicine Centre and Cardiology Program, Hospital Israelita Albert Einstein, São Paulo, Brazil. Electronic address: [email protected]Samuel S. GiddingNemours Cardiac Center, A I DuPont Hospital for Children, Wilmington, DE, USARobert A. HegeleDepartment of Medicine and Robarts Research Institute, Schulich School of Medicine, Western University, London, ON, CanadaMarina CuchelDivision of Translational Medicine and Human Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USAPhilip J. BarterSchool of Medical Sciences, University of New South Wales, Sydney, NSW, AustraliaGerald F. WattsLipid Disorders Clinic, Royal Perth Hospital, The University of Western Australia, Perth, WA, AustraliaSeth J. BaumPreventive Cardiology, Christine E Lynn Women's Health & Wellness Institute, Boca Raton Regional Hospital, Boca Raton, FL, USAAlberico L. CatapanoDepartment of Pharmacological and Biomolecular Sciences, University of Milan, Milan, Italy; IRCCS Multimedica, Milan, ItalyM. John ChapmanPitié-Sâlpetrière University Hospital, Paris, FranceJoep C. DefescheUniversity of Amsterdam, Academic Medical Center (AMC), Amsterdam, NetherlandsEmanuela FolcoInternational Atherosclerosis Society, Milan, ItalyTomáš FreibergerMolecular Genetics Lab, Centre for Cardiovascular Surgery and Transplantation, and Ceitec, Masaryk University, Brno, Czech RepublicJacques GenestMcGill University Health Center, Royal Victoria Hospital, Montreal, QC, CanadaG. Kees HovinghUniversity of Amsterdam, Academic Medical Center (AMC), Amsterdam, NetherlandsMariko Harada‐ShibaNational Cerebral and Cardiovascular Center Research Institute, Suita, Osaka, JapanSteve E. HumphriesCentre for Cardiovascular Genetics, Institute of Cardiovascular Science, University College of London, London, UKAnn S JacksonInternational Atherosclerosis Society, Houston, TX, USAPedro MataPatrick M. MoriartyAtherosclerosis and Lipoprotein-Apheresis Center, University of Kansas Medical Center, Kansas City, KS, USAFrederick J. RaalFaculty of Health Sciences, University of the Witwatersrand, Johannesburg, South AfricaKhalid Al‐RasadiSultan Qaboos University Hospital, Muscat, OmanKausik K. RaySchool of Public Health, Imperial College London, London, UKZelijko ReinerEuropean Association for Cardiovascular Prevention and Rehabilitations, Zagreb, CroatiaEric J.G. SijbrandsDepartment of Internal Medicine, Erasmus MC, Rotterdam, NetherlandsShizuya YamashitaOsaka University Graduate School of Medicine, Suita, Osaka, Japan
2016en
ABI
Аннотация
Аннотация отсутствует.
Идентификаторы
Цитирования и источники
Цитирований: 2Использованных источников: 0